Literature DB >> 21895679

Report of the fourth International Workshop on molecular blood group genotyping.

G Daniels1, C E van der Schoot, M L Olsson.   

Abstract

The fourth International Society of Blood Transfusion (ISBT) workshop on molecular blood group genotyping was held in 2010, with a feedback meeting at the ISBT Congress in Berlin, Germany. Fifty laboratories participated, 17 more than in 2008. Six samples were distributed. Samples 1-3 were DNA samples for all red cell blood group tests available to the participants. Of the 46 laboratories that tested these samples, 37 obtained completely correct results, although the extent of testing varied considerably. Sample 4, also a DNA sample, was an Rh problem in which RHDΨ and RHCE*ceCF were present, but the participants were only informed that the donor's red cells typed as positive with some monoclonal anti-D. Of the 42 laboratories that participated in this exercise, seven performed the sequencing necessary to obtain the correct result. Samples 5 and 6 were plasma samples from RhD-negative pregnant women, for foetal RhD testing. These were sent to 25 laboratories, and two incorrect results were reported. Overall, the level of accuracy was about equal to that of the previous workshop. The main conclusion for the last two workshops can be reiterated: with greater care and attention to detail, very high standards could be set for molecular blood group genotyping.
© 2011 The Author(s). Vox Sanguinis © 2011 International Society of Blood Transfusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21895679     DOI: 10.1111/j.1423-0410.2011.01540.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  7 in total

1.  Applying molecular immunohaematology to regularly transfused thalassaemic patients in Thailand.

Authors:  Pairaya Rujirojindakul; Willy A Flegel
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

2.  Performance of a microarray-based genotyping system for red cell and platelet antigens in China.

Authors:  Luyi Ye; Jiamin Zhang; Chen Wang; Qixiu Yang; Shasha Han; Ziyan Zhu
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Non-invasive foetal RhD genotyping to guide anti-D prophylaxis: an external quality assurance workshop.

Authors:  Frederik B Clausen; Angela N Barrett; Grethe R Krog; Kirstin Finning; Morten H Dziegiel
Journal:  Blood Transfus       Date:  2017-04-05       Impact factor: 3.443

4.  External quality assessment in molecular immunohematology: the INSTAND proficiency test program.

Authors:  Willy A Flegel; Ion Chiosea; Ulrich J Sachs; Gregor Bein
Journal:  Transfusion       Date:  2013-09-20       Impact factor: 3.157

5.  Non-invasive foetal RhD genotyping in admixed populations.

Authors:  Frederik B Clausen
Journal:  Blood Transfus       Date:  2016-03-21       Impact factor: 3.443

Review 6.  Red cell genotyping precision medicine: a conference summary.

Authors:  Gregory A Denomme; Waseem Q Anani; Neil D Avent; Gregor Bein; Lynne B Briggs; Razvan C Lapadat; Celina Montemayor; Maria Rios; Maryse St-Louis; Lynne Uhl; Silvano Wendel; Willy A Flegel
Journal:  Ther Adv Hematol       Date:  2017-09-13

7.  Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.

Authors:  Tadeja Dovč-Drnovšek; Polona Klemenc; Nataša Toplak; Tanja Blejec; Irena Bricl; Primož Rožman
Journal:  Transfus Med Hemother       Date:  2013-01-03       Impact factor: 3.747

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.